Koning Health has launched its Series C fundraising round in partnership with Sage Tap Poder SPV, aiming to accelerate the commercial expansion of the Koning Vera Breast CT—the first and only FDA-approved 3D breast imaging system for diagnostic use. Unlike traditional mammography, the Koning Vera offers high-resolution, full 360-degree breast imaging without compression, discomfort, or radiation overdosing. Its AI-driven technology captures a detailed scan in just seven seconds per breast, making it especially valuable for detecting abnormalities in dense breast tissue and improving patient comfort and compliance.

The funding and strategic coordination with Sage Tap Poder will support Koning's next phase of growth, including widespread deployment of the device in U.S. clinics and hospitals, advancement of reimbursement strategies, and deeper engagement with radiologists. This partnership brings together medical innovation and investment expertise, opening new opportunities for verified accredited investors to support a breakthrough in women’s health. With increasing demand for non-invasive, precise diagnostics, the Koning Vera is well-positioned to become the new standard in routine breast imaging worldwide.

This collaboration underscores a shared commitment to transforming breast cancer detection and prevention through patient-centered innovation. As the device gains traction in domestic and global markets, it holds the potential to significantly reduce diagnostic delays, improve outcomes, and expand access to life-saving care across underserved regions. The Series C raise marks a pivotal step in Koning Health’s journey to redefine breast imaging and deliver a smarter, safer, and more effective future for women’s healthcare.